Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

An expert has explained that if you take weight-loss drugs you might get 'Ozempic mouth', though it's not all bad.

Stealthy, subtle facelifts are on the rise, and it’s not just celebrities who are going under the knife. Katie Rosseinsky ...

The molecule is semaglutide, and it's sold under the name ... They are large molecule drugs, so complex in structure and must be administered by injection. Importantly, Novo Nordisk's and Lilly's ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

DELRAY BEACH, Fla., April 24, 2025 /PRNewswire/ -- The global Oral Proteins & Peptides Market , valued at US$7.35 billion in 2024, is forecasted to grow at a robust CAGR of 22.1%, reaching US$8.85 ...

But now, he says, the treatment has evolved with a better “understanding of the deeper structure of the face ... Those who take semaglutide (often known by brand names such as Ozempic or ...

Lilly markets its dual GIP and GLP-1 receptor agonist, tirzepatide, as Mounjaro for T2D and Zepbound for obesity, while Novo Nordisk markets its semaglutide drugs as Ozempic for T2D and Wegovy for ...

Shares of Eli Lilly LLY soared 14.3% on April 17 after data from a late-stage study showed that orforglipron achieved the ...